These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 9125176

  • 41. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis.
    Oliverio S, Amendola A, Di Sano F, Farrace MG, Fesus L, Nemes Z, Piredda L, Spinedi A, Piacentini M.
    Mol Cell Biol; 1997 Oct; 17(10):6040-8. PubMed ID: 9315663
    [Abstract] [Full Text] [Related]

  • 42. Hoechst 33342-induced apoptosis is associated with intracellular accumulation of E2F-1 protein in BC3H-1 myocytes and HL-60 cells.
    Zhang X, Kiechle FL.
    Arch Pathol Lab Med; 2001 Jan; 125(1):99-104. PubMed ID: 11151061
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of Ku autoantigen binding activity to the E2F motif after ultraviolet B irradiation of melanocytic cells.
    Pedley J, Pettit A, Parsons PG.
    Melanoma Res; 1998 Dec; 8(6):471-81. PubMed ID: 9918408
    [Abstract] [Full Text] [Related]

  • 44. Cell cycle-specific and transcription-related phosphorylation of mammalian topoisomerase I.
    D'Arpa P, Liu LF.
    Exp Cell Res; 1995 Mar; 217(1):125-31. PubMed ID: 7867711
    [Abstract] [Full Text] [Related]

  • 45. Functional analysis of E2F transcription factor.
    Nevins JR, DeGregori J, Jakoi L, Leone G.
    Methods Enzymol; 1997 Mar; 283():205-19. PubMed ID: 9251021
    [No Abstract] [Full Text] [Related]

  • 46. A microgonotropen branched decaaza decabutylamine and its DNA and DNA/transcription factor interactions.
    Bruice TC, Sengupta D, Blaskó A, Chiang SY, Beerman TA.
    Bioorg Med Chem; 1997 Apr; 5(4):685-92. PubMed ID: 9158867
    [Abstract] [Full Text] [Related]

  • 47. Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region.
    He Y, Armanious MK, Thomas MJ, Cress WD.
    Oncogene; 2000 Jul 13; 19(30):3422-33. PubMed ID: 10918599
    [Abstract] [Full Text] [Related]

  • 48. (Re-)Engineering tumor cell-selective replicating adenoviruses: a step in the right direction toward systemic therapy for metastatic disease.
    Dubensky TW.
    Cancer Cell; 2002 May 13; 1(4):307-9. PubMed ID: 12086842
    [Abstract] [Full Text] [Related]

  • 49. Comprehensive Phosphoproteomic Analysis of Pepper Fruit Development Provides Insight into Plant Signaling Transduction.
    Liu Z, Lv J, Liu Y, Wang J, Zhang Z, Chen W, Song J, Yang B, Tan F, Zou X, Ou L.
    Int J Mol Sci; 2020 Mar 13; 21(6):. PubMed ID: 32183026
    [Abstract] [Full Text] [Related]

  • 50. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
    Su S, Minges JT, Grossman G, Blackwelder AJ, Mohler JL, Wilson EM.
    J Biol Chem; 2013 Aug 23; 288(34):24809-24. PubMed ID: 23853093
    [Abstract] [Full Text] [Related]

  • 51. E2F-1 binding affinity for pRb is not the only determinant of the E2F-1 activity.
    Sahin F, Sladek TL.
    Int J Biol Sci; 2010 Jul 04; 6(4):382-95. PubMed ID: 20616879
    [Abstract] [Full Text] [Related]

  • 52. E2F-1 has dual roles depending on the cell cycle.
    Sahin F, Sladek TL.
    Int J Biol Sci; 2010 Mar 03; 6(2):116-28. PubMed ID: 20224733
    [Abstract] [Full Text] [Related]

  • 53. E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.
    Advani SJ, Weichselbaum RR, Roizman B.
    J Virol; 2000 Sep 03; 74(17):7842-50. PubMed ID: 10933691
    [Abstract] [Full Text] [Related]

  • 54. Novel phosphorylated forms of E2F-1 transcription factor bind to the retinoblastoma protein in cells overexpressing an E2F-1 cDNA.
    Yang XH, Sladek TL.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):336-9. PubMed ID: 9125176
    [Abstract] [Full Text] [Related]

  • 55. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
    Rampalli AM, Gao CY, Chauthaiwale VM, Zelenka PS.
    Oncogene; 1998 Jan 22; 16(3):399-408. PubMed ID: 9467965
    [Abstract] [Full Text] [Related]

  • 56. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X, Cress WD, Zhong Q, Zuckerman KS.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):930-9. PubMed ID: 11027571
    [Abstract] [Full Text] [Related]

  • 57. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro.
    Peeper DS, Keblusek P, Helin K, Toebes M, van der Eb AJ, Zantema A.
    Oncogene; 1995 Jan 05; 10(1):39-48. PubMed ID: 7824278
    [Abstract] [Full Text] [Related]

  • 58. Regulation of cell proliferation by the E2F transcription factors.
    Helin K.
    Curr Opin Genet Dev; 1998 Feb 05; 8(1):28-35. PubMed ID: 9529602
    [Abstract] [Full Text] [Related]

  • 59. Novel phosphorylated forms of E2F-1 transcription factor bind to the retinoblastoma protein in cells overexpressing an E2F-1 cDNA.
    Yang XH, Sladek TL.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):336-9. PubMed ID: 9125176
    [Abstract] [Full Text] [Related]

  • 60. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
    Rampalli AM, Gao CY, Chauthaiwale VM, Zelenka PS.
    Oncogene; 1998 Jan 22; 16(3):399-408. PubMed ID: 9467965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.